WINTON GROUP Ltd bought a new position in shares of DocuSign, Inc. (NASDAQ:DOCU) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 1,512 shares of the company’s stock, valued at approximately $423,000.
Other hedge funds also recently made changes to their positions in the company. Red Door Wealth Management LLC bought a new position in DocuSign during the second quarter worth $26,000. Bartlett & Co. LLC bought a new stake in DocuSign in the 2nd quarter valued at $28,000. Burleson & Company LLC bought a new stake in DocuSign in the 1st quarter valued at $31,000. PNC Managed Account Solutions Inc. bought a new stake in DocuSign in the 2nd quarter valued at $37,000. Finally, Clearview Wealth Advisors LLC increased its holdings in DocuSign by 58.3% in the 2nd quarter. Clearview Wealth Advisors LLC now owns 152 shares of the company’s stock valued at $42,000 after buying an additional 56 shares during the period. 75.67% of the stock is currently owned by institutional investors and hedge funds.
Shares of NASDAQ DOCU opened at $271.16 on Wednesday. The firm’s 50-day simple moving average is $292.20 and its 200 day simple moving average is $249.21. The company has a market cap of $53.34 billion, a price-to-earnings ratio of -315.30 and a beta of 0.84. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 3.45. DocuSign, Inc. has a 12-month low of $179.49 and a 12-month high of $314.76.
Several brokerages have issued reports on DOCU. Evercore ISI boosted their price target on shares of DocuSign from $285.00 to $320.00 and gave the company an “outperform” rating in a report on Friday, September 3rd. Needham & Company LLC boosted their price target on shares of DocuSign from $275.00 to $340.00 and gave the company a “buy” rating in a report on Friday, September 3rd. Royal Bank of Canada boosted their target price on shares of DocuSign from $280.00 to $345.00 and gave the company an “outperform” rating in a research note on Friday, September 3rd. UBS Group boosted their target price on shares of DocuSign from $340.00 to $350.00 and gave the company a “buy” rating in a research note on Friday, September 3rd. Finally, Citigroup restated a “buy” rating and issued a $389.00 target price (up previously from $386.00) on shares of DocuSign in a research note on Friday, September 3rd. Four equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $309.20.
In other DocuSign news, CRO Loren Alhadeff sold 6,387 shares of the business’s stock in a transaction dated Friday, September 17th. The stock was sold at an average price of $276.44, for a total transaction of $1,765,622.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Scott V. Olrich sold 12,500 shares of the company’s stock in a transaction dated Tuesday, July 13th. The shares were sold at an average price of $285.61, for a total value of $3,570,125.00. The disclosure for this sale can be found here. Insiders have sold a total of 92,931 shares of company stock valued at $27,725,426 over the last three months. Company insiders own 3.87% of the company’s stock.
DocuSign, Inc provides cloud-based electronic signature solutions. Its cloud based electronic signature platform helps companies and individuals securely collect information, automate data workflows and sign anything. The firm automates manual, paper-based processes allowing users to manage all aspects of documented business transactions include identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation and storage.
Featured Article: What is the CBOE Russell 2000® Volatility Index?
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.